Ahn-Gook Pharmaceutical Co. Ltd (001540) — Capital Reinvestment Ratio
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩14.44 Billion) in capital expenditures (₩2.76 Billion). See Ahn-Gook Pharmaceutical Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Ahn-Gook Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 001540 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see Ahn-Gook Pharmaceutical Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 15.44x | ₩4.91 Billion | ₩75.89 Billion | ▲ +842.3% |
| 2022 | 1.64x | ₩1.79 Billion | ₩2.93 Billion | ▼ -40.2% |
| 2021 | 2.74x | ₩1.47 Billion | ₩4.04 Billion | ▲ +27.2% |
| 2020 | 2.16x | ₩11.19 Billion | ₩24.12 Billion | ▲ +1173.0% |
| 2019 | 0.17x | ₩22.08 Billion | ₩3.74 Billion | ▼ -38.3% |
| 2017 | 0.27x | ₩17.46 Billion | ₩4.79 Billion | ▼ -20.9% |
| 2016 | 0.35x | ₩12.62 Billion | ₩4.38 Billion | ▲ +184.5% |
| 2015 | 0.12x | ₩19.11 Billion | ₩2.33 Billion | ▼ -97.8% |
| 2014 | 5.56x | ₩1.29 Billion | ₩7.16 Billion | ▲ +207.2% |
| 2013 | 1.81x | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩11.51 Billion | ₩2.58 Billion | — |